EP Biocomposites (BOM:543595) EBIT per Share: ₹13.54 (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:543595 EP Biocomposites Ltd BOM:543595
81 GF Score
Price ₹94.55
GF Value ₹203.06
Valuation Significantly Undervalued
! 6 Warning Signs
View Full Analysis

What is EP Biocomposites EBIT per Share?

EP Biocomposites BOM:543595 81 EBIT per Share is ₹13.54 as of Mar. 2026. GuruFocus rates BOM:543595 with a GF Score™ of 81/100 and a GF Value™ of ₹203.06 (Significantly Undervalued). The stock has 6 warning signs investors should review. Among 1,395 Construction companies, EP Biocomposites ranks better than 71.9% on this metric.

EP Biocomposites's EBIT per Share for the six months ended in Mar. 2026 was ₹11.92. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹13.54.

During the past 12 months, the average EBIT per Share Growth Rate of EP Biocomposites was 28.50% per year. During the past 3 years, the average EBIT per Share Growth Rate was 28.30% per year. During the past 5 years, the average EBIT per Share Growth Rate was 27.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for EP Biocomposites's EBIT per Share or its related term are showing as below:

BOM:543595' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 7.4   Med: 37.25   Max: 178.6
Current: 28.3

During the past 8 years, the highest 3-Year average EBIT per Share Growth Rate of EP Biocomposites was 178.60% per year. The lowest was 7.40% per year. And the median was 37.25% per year.

BOM:543595's 3-Year EBIT Growth Rate is ranked better than
71.9% of 1395 companies
in the Construction industry
Industry Median: 9.2 vs BOM:543595: 28.30

EP Biocomposites's EBIT for the six months ended in Mar. 2026 was ₹20.1 Mil.


EP Biocomposites  (BOM:543595) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.


EP Biocomposites EBIT per Share Related Terms


EP Biocomposites EBIT per Share Historical Data

* Premium members only.

The historical data trend for EP Biocomposites's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EP Biocomposites EBIT per Share Chart

EP Biocomposites Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EBIT per Share
Get a 7-Day Free Trial 7.86 6.96 9.54 10.53 13.54

EP Biocomposites Semi-Annual Data
Mar19 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
EBIT per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.70 2.85 7.68 1.62 11.92
BOM:543595
81GF Score
EP Biocomposites Ltd BOM:543595
EBIT per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

EP Biocomposites EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

EP Biocomposites's EBIT per Share for the fiscal year that ended in Mar. 2026 is calculated as

EBIT per Share(A: Mar. 2026 )
=EBIT/Shares Outstanding (Diluted Average)
=22.772/1.682
=13.54

EP Biocomposites's EBIT per Share for the quarter that ended in Mar. 2026 is calculated as

EBIT per Share(Q: Mar. 2026 )
=EBIT/Shares Outstanding (Diluted Average)
=20.064/1.683
=11.92

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹13.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT per Share →
What does a EBIT per Share of ₹13.54 mean?
EP Biocomposites (BOM:543595) has a EBIT per Share of ₹13.54 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on EP Biocomposites and its competitors. According to the industry distribution chart, EP Biocomposites ranks #392 out of 1395 companies in the Construction industry, placing it in the top 28.1%.
Is EP Biocomposites' EBIT per Share too high?
EP Biocomposites' current EBIT per Share is ₹13.54. Based on the distribution chart, EP Biocomposites ranks #392 out of 1395 companies in the Construction industry, which is above the industry midpoint. Overall, EP Biocomposites has a GF Score™ of 81/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does EP Biocomposites' EBIT per Share compare to TT and JCI?
According to the Construction industry distribution chart, EP Biocomposites ranks #392 out of 1395 companies for EBIT per Share. This puts EP Biocomposites in the upper half of its industry. The industry median EBIT per Share is 9.20. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Construction company?
The median EBIT per Share among Construction companies is 9.20, based on 1,395 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on EP Biocomposites and its competitors. For the Construction industry, the median EBIT per Share is 9.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EP Biocomposites's current EBIT per Share is ₹13.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EP Biocomposites stock overvalued right now?
Based on GuruFocus' analysis, EP Biocomposites (BOM:543595) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹203.06, compared to a current price of ₹94.55 — trading 53.4% below its estimated fair value. The current EBIT per Share is ₹13.54. EP Biocomposites' overall GF Score™ is 81/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For EP Biocomposites (BOM:543595), the current EBIT per Share is ₹13.54 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is EP Biocomposites (BOM:543595) Overvalued in 2026?

Based on GuruFocus' analysis, EP Biocomposites stock appears to be undervalued. The current stock price of ₹94.55 is trading 53.4% below its estimated GF Value™ of ₹203.06. GuruFocus considers EP Biocomposites to be Significantly Undervalued.

Key valuation signals for BOM:543595:

  • EBIT per Share: ₹13.54
  • GF Value™: ₹203.06 vs. price of ₹94.55 (53.4% below fair value)
  • GF Score™: 81/100 with 6 warning signs

No single metric tells the full story. See the BOM:543595 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


EP Biocomposites Business Description

Address 1st Floor, B.R. Commercial Centre, Opposite Parade Grounds, Campal, Panaji, GA, IND, 403001
EP Biocomposites Ltd is the manufacturer and supplier of fibre reinforced polymers products such as door shutters, frames, Biodigestor Tanks, Bio toilets and allied products for construction and Industrial applications. The company focus on giving sanitation solutions to those who do not have access to toilets, as well as to those who have toilets but face trouble treating and managing the waste through septic tanks. The company also provides sanitation infrastructure and human waste management solutions and services, involving simple bio-digester technology licensed from the Defence Research and Development Organisation (DRDO) and Industry Interface and Technology Management, operating under the aegis of DRDO, Ministry of Defence, Government of India.
81GF Score

Get the complete analysis for BOM:543595

EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹94.55
Price
₹203.06
GF Value